Ángela
Ibáñez Cuadrado
Profesor/a Asociado/a en CC. de la Salud
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (18)
2024
-
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations
Schizophrenia Research, Vol. 267, pp. 534-545
2023
-
Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis
Acta Psychiatrica Scandinavica
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
2022
-
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia
Schizophrenia Research, Vol. 243, pp. 32-42
-
Epigenetic clocks in relapse after a first episode of schizophrenia
Schizophrenia, Vol. 8, Núm. 1
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
-
The network structure of cognitive deficits in first episode psychosis patients
Schizophrenia Research, Vol. 244, pp. 46-54
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Translational Psychiatry, Vol. 11, Núm. 1
-
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176
-
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis
Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676
2020
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort
Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552
2019
-
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis
European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794
2017
-
Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset
Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422
2016
-
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4
2015
2014
-
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia
Journal of Clinical Psychiatry, Vol. 75, Núm. 6, pp. 608-615
2012
-
Protocolo breve de evaluación del suicidio: Fiabilidad interexaminadores
Revista de Psiquiatria y Salud Mental, Vol. 5, Núm. 1, pp. 24-36